The US Food and Drug Administration criticized Xeris Pharmaceuticals, Inc.'s Gvoke PFS (glucagon pre-filled syringe) television advertisement for leaving out serious risks associated with the diabetes drug and claiming it is easy to use.
In a 14 August
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?